Drug discovery: Historical perspective, current status, and outlook

Comprehensive Medicinal Chemistry II

Volumn 1, Issue , 2006, Pages 29-96

  Erhardt, P W ^a   Proudfoot, J R ^b  

^a UNIVERSITY OF TOLEDO   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882475409     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (472)

1. Erhardt, P. W Pure Appl. Chem. 2002, 74, 703-785.
2. Cotton, F A. Chem. Eng. News 2000, Dec 4, 5.
3. Stokes, D. E. Pasteur's Quadrant: Basic Science and Technological Innovation; Brookings Press: Washington, DC, 1997.
4. Reisch, M. S. Chem. Eng. News 2001, Feb 12, 15-17.
5. The Pharmaceutical Century; Jacobs, M., Newman, A., Ryan, J., Eds.; American Chemical Society: Washington, DC, 2000.
6. Medicinal Chemistry Part 1, 3rd ed.; Burger, A., Ed.; Wiley-Interscience: New York, 1970 (first published in 1951).
7. Textbook of Organic Medicinal and Pharmaceutical Chemistry; 6 th ed.; Wilson, C. O., Gisvold, O., Doerge, R. F, Eds.; Lippincott: Philadelphia, PA, 1971 (first published in 1949).
8. Inorganic Medicinal and Pharmaceutical Chemistry; Block, J. H., Roche, E. B., Soine, T O., Wilson, C. O., Eds.; Lee and Febiger: Philadelphia, PA, 1974.
9. Erhardt, P. W Drug Metabolism Data Past Present and Future Considerations. In Drug Metabolism: Databases and High-Throughput Testing During Drug Design and Development; Erhardt, P. W, Ed.; IUPAC/Blackwell: Boston, MA, 1999, pp 2-15.
10. Erhardt, P. W In Chronicles of Drug Discovery; Lednicer, D., Ed.; American Chemical Society: Washington, DC, 1993, pp 191-206.
11. Venuti, M. C. Ann. Rep. Med. Chem. 1990, 25, 289-298.
12. Oldenburg, K. R. Ann. Rep. Med. Chem. 1998, 33, 301-311.
13. Ausman, D. J. Modern Drug Disc. 2001, Jan, 18-23.
14. Felton, M. J. Modern Drug Disc. 2001, Jan, 24-28.
15. Hylands, P J.; Nisbet, L. J. Ann. Rep. Med. Chem. 1991, 26, 259-269.
16. Dower, W. J.; Fodor, S. P. Ann. Rep. Med. Chem. 1991, 26, 271-280.
17. Moos, W H.; Green, G. D.; Pavia, M. R. Ann. Rep. Med. Chem. 1993, 28, 315-324.
18. Gallop, M. A.; Barrett, R. W; Dower, W J.; Fodor, S.; Gordon, E. M. J. Med. Chem. 1994, 37, 1234-1251.
19. Gordon, E. M.; Barrett, R. W; Dower, W J.; Fodor, S.; Gallop, M. A. J. Med. Chem. 1994, 37, 1385-1401. American Chemical Society: New York, 1998.
20. Terrett, N. K. Combinatorial Chemistry;
21. Trainor, G. L. Ann. Rep. Med. Chem. 1999, 34, 267-286.
22. Kyranos, J. N.; Hogan, J. C., Jr. Modern Drug Disc. 1999, July j Aug, 73-82.
23. Brown, R. K. Modern Drug Disc. 1999, July/Aug, 63-71.
24. Borman, S. Chem. Eng. News 2000, May 15, 53-65.
25. LeProust, E.; Pellois, J. P.; Yu, P; Zhang, H.; Gao, X. J. Comb. Chem. 2000, 2, 349-354.
26. Scharn, D.; Wenschuh, H.; Reineke, U.; Schneider-Mergener, J.; Germeroth, L. J. Comb. Chem. 2000, 2, 361-369.
27. Dolle, R. E. Mod. Drug Disc. 2001, Feb, 43-8 (the complete survey article which appeared in J. Comb. Chem. 2000, 2, 383-33 and includes 290 references, 10 tables, and 26 figures, is also available on the web at http://pubs.acs.org/hotarticl/jcchff/2000/cc000055xrev.html).
28. Boguslavsky, J. Drug Disc. Dev. 1999, Sept, 71.
29. Karet, G. Drug Disc. Dev. 2000, Mar, 28-32.
30. U'Prichard, D. C. Drug Disc. World 2000, Fall, 12-22.
31. From Bench to Market; Cabri, W, Di Fabio, R., Eds.; Oxford University Press: New York, 2000.
32. Knapman, K. Modern Drug Disc. 2000, June, 75-77.
33. Hume, S. Innov. Pharm. Tech. 2000, 6, 108-111.
34. Court, J.; Oughton, N. Innov. Pharm. Tech. 2000, 6, 113-117.
35. M. D. Lemonick, Time 2001, Jan 15, 58-67.
36. Zall, M. Modern Drug Disc. 2001, Mar, 37-42.
37. Brennan, M. B. Chem. Eng. News 2000, Feb 14, 81-84.
38. Paul Erhardt personal communications while visiting several big pharma during 2000-2004.
39. Strader, C. D. J. Med. Chem. 1996, 39, 1.
40. Hanson, D. Chem. Eng. News 2000, June 19, 37.
41. Jacobs, M. Chem. Eng. News 2000, Oct 30, 43-49.
42. Kubinyi, H. Curr. Opin. Drug Disc. Dev. 1998, 1, 4-15.
43. Murcko, M. A.; Caron, P. R.; Charifson, P S. Annu. Rep. Med. Chem. 1999, 34, 297-306.
44. Rubens tein, K. Drug and Market Development 2000, Report 1993, 1-200.
45. Josephson, J. Modern Drug Disc. 2000, May, 45-50.
46. Karet, G. Drug Disc. Dev. 1999, Nov/Dec, 71-74.
47. Lesney, M. S. Modern Drug Disc. 2000, May, 31-32.
48. Brennan, M. B. Chem. Eng. News 2000, June 5, 63-73.
49. F Golden, Time 2001, Jan 15, 74-76.
50. Thayer, A. Chem. Eng. News 2001, Feb 5, 18.
51. Clinical trial information available on the Internet: Royal Coll. Physicians of Edinburgh at http://www.rcpe.ac.uk/cochrane/intro.html; Pharmaceutical Information Network at http://pharminfo.com/conference/clintrial/fda1.html; PhRMA (association of 100 major pharmaceutical companies) at http://www.pharma.org/charts/approval.html; Univ. Pittsburgh IRB manual at http://www.ofreshs.upmc.edu/irb/preface.htm; Center Watch (a comprehensive venue and listing for clinical trials) at http://www.centerwatch.com; FDA Center for Drug Evaluation and Research (CDER) at http://www.fda.gov/cder; eOrange Book (approved drug products with therapeutic equivalence evaluations) at http://www.fda.gov/cder/ob.; FDA CDER Handbook at http://www.fda.gov/cder/handbook/index.htm; FDA CDER Fact Book 1997 at http://www.fda.gov/cder/reports/cderfact.pdf; FDA Consumer Magazine at http://www.fda.gov/fdac/fdacindex.html; FDA Guidelines on content and format for INDs at http://www.fda.gov/cder/guidance/clin2.pdf (accessed Aug 2006).
52. Karet, G. Drug Disc. Dev. 2000, June/July, 34-0.
53. Moran, S.; Stewart, L. Drug Disc. World 2000, Fall, 41-46.
54. Wu, Z. P. Accelerating Lead and Solid Form Selection in Drug Discovery and Development Using Non-Ambient X-Ray Diffraction; New Chemical Technologies Satellite Program, 221st National ACS Meeting, March 2001.
55. Pearlman, D. A.; Charifson, P S. J. Med. Chem. 2001, 44, 502-511.
56. Schoenlein, R. W; Chattopadhyay, S.; Chong, H. H. W; Glover, T E.; Heimann, P A.; Shank, C. V.; Zholents, A. A.; Zolotorev, M. S. Science 2000, 287, 2237-2240.
57. Wilson, E. Chem. Eng. News 2000, Mar 27, 7-8.
58. Yarnell, A. Chem. Eng. News 2005, Feb 8, 13.
59. Flores, T; Garcia, D.; McKenzie, T; Pettigrew, J. Planning for Knowledge-Led R&D. In Innovations in Pharmaceutical Technology; Barnacal, P. A., Ed.; Chancery Media: London, 2000, pp 18-22.
60. Studt, T Drug Disc. Dev. 2000, Mar, 7.
61. Hodgkin, E.; Andrews-Cramer, K. Modern Drug Disc. 2000, Jan/Feb, 55-60.
62. Sleep, N. Modern Drug Disc. 2000, July/Aug, 37-42.
63. Karet, G. Drug Disc. Dev. 1999, Nov/Dec, 39-43.
64. Boguslavsky, J. Drug Disc. Dev. 2000, Mar, 67.
65. Young, S.; Li, J. Drug Disc. Dev. 2000, Apr, 34-37.
66. Brennan, M. B. Chem. Eng. New. 2000, June 5, 63-73.
67. Estrada, E.; Uriarte, E.; Montero, A.; Teijeira, M.; Santana, L.; De Clercq, E. J. Med. Chem. 2000, 43, 1975-1985.
68. Boehm, H.-J.; Boehringer, M.; Bur, D.; Gmuender, H.; Huber, W.; Klaus, W; Kostrewa, D.; Kuehne, H.; Luebbers, T; Meunier-Keller, N. et al. J. Med. Chem. 2000, 43, 2664-2674.
69. Bissantz, C.; Folkers, G.; Rognan, D. J. Med. Chem. 2000, 43, 4759-4767.
70. Waterbeemd, H. vande.; Gifford, E. Nat. Rev. 2003, 2, 192-204.
71. Lombardo, F; Gifford, E.; Shalaeva, M. Y Mini Rev. Med. Chem. 2003, 3, 861-875.
72. Brown, F K. Annu. Rep. Med. Chem. 1998, 33, 375-384.
73. Hann, M.; Green, R. Curr. Opin. Chem. Biol. 1999, 3, 379-383.
74. Ertl, P; Miltz, W; Rohde, B.; Selzer, P Drug Disc. World 2000, 1, 45-50.
75. ChemFinder at http://www.chemfinder.com; Chem Navigator at http://www.chemnavigator.com; Info Chem GmbH at http://www.info-chem.com; Institute for Scientific Info. at http://www.isinet.com; MDL Information Systems at http://www.mdli.com; MSI at http://www.msi.com; Oxford Molecular at http://www.oxmol.com; Pharmacopeia at http://www.pharmacopeia.com; QsarIS at http://www.scivision.com/qsaris.html; Synopsys Scientific Systems at http://www.synopsys.co.uk; Tripos at www.tripos.com (accessed Aug 2006).
76. Interactive video conference the role of higher education in economic development. Old Dominion Univ. Academ. Television Serv. 1997, Jan. 31, http://www.utoledo.edu (accessed Aug 2006).
77. Erhardt, P. W Preface. In Drug Metabolism:-Databases and High-Throughput Testing during Drug Design and ; Erhardt, P W, Ed.; IUPAC/Blackwell Science: London, 1999, pp viii-ix.
78. Ausman, D. Molecular Connection (MDL 's Newsletter) 1999, 18, 3.
79. Recupero, A. J. Drug Disc. Dev. 1999, Nov/Dec, 59-62.
80. Agres, T Drug Disc. Dev. 2000, Jan/Feb, 11-12.
81. Studt, T Drug Disc. Dev. 2000, Jan/Feb, 68-69.
82. Zarrabian, S. Chem. Eng. News 2000, Feb 7.
83. Thayer, A. M. Chem. Eng. News 2000, Feb 7, 19-32.
84. Tye, S.; Karet, G. Drug Disc. Dev. 2000, Mar, 35.
85. Schulz, W Chem. Eng. News 2001, Feb 5, 25.
86. DARPA at http://www.darpa.mil; FAO at http://www.fao.org/GENINFO/partner/defautl.htm; Gen Bank at http://www.ncbi.nlm.nih.gov/entrez/nucleotide.html; DDBJ at http://www.ddbj.nig.ac.jp/; EMBL at http://www.ebi.ac.uk/ebidocs/embldb/ebi/topembl.html; Human Genome Sequencing at http://www.ncbi.nlm.nih.gov/genome/seq; KEEGG 12.0 at http://www.genome.ad.jp/kegg/; NASA at http://www.nasa.gov; Nat. Acad. Sci. STEP at http://www4.nas.edu/pd/step.nsf; Nat. Ctr. Biotech. Info. at http://www.ncbi.nlm.nih.gov; Nat. Human Genome Res. Inst. at http://www.nhgri.nih.gov/index.html; Nat. Sci. Fndn. Math/Phys. Sci. at http://www.nsf.gov/home/mps/start.htm; Net Genics 'SYNERGY' at http://www.netgenics.com/SYNERGY.html; Pfam 4.3 at pfam.wustl.edu/; PROSITE at http://www3.oup.co.uk/nar/Volume27/Issue01/html/gkc073gml.html#hdO; Sanger Ctr. At http://www.sanger.ac.uk/; SRS at http://www.embl-heidelberg-de/srs51; TIGER Database at http://www.tigr.org/tdb/tdb.html; UNESCO at http://www.unesco.org/general/eng./programmes/science/life/index.htm; Univ. Cal. Berkeley at http://www.Berkeley.edu (accessed Aug 2006).
87. Paul Erhardt personal communications while attending several recent workshops directed toward expediting drug development.
88. Protein Data Bank. org/bdb/(accessed Aug 2006).
89. Biotech Validation Suite For Protein Structure at http://biotech.embl-heidelberg.de:8400/; BLAST at http://www.ncbi.nlm.nih.gov/BLAST/; Build Proteins From Scratch at http://csb.stanford.edu/levitt and http://www.chem.cornell.edu/department/Faculty/Scheraga/Scheraga.html; CATH at http://www.biochem.ucl.ac.uk/bsm/cath/; FASTA at http://www2.ebi.ac.uk/fasta3/; MODELLER at http://guitar.rockfeller.edu; PDB at http://www.pdb.bnl.gov/; Pedant at MIPS at http://pedant.mips.biochem.mpg.del; PIR at http://www.nbrf.georgetown.edu/pir/searchdb.html; Predict Protein at http://www.embl-heidelber.de/predictprotein/predictprotein.html; PSIPRED at http://insulin.brunel.ac.uk/psipred; Rosetta at http://depts.Washington.edu/bakerpg; SAM-98 at http://www.cse.ucsc.edu/research/compbio; SCOP at http://scop.mrc-lmb.cam.ac.uk/sopl; Structure at http://www.ncbi.nlm.nih.gov/Structure/RESEARCH/res.shtml; Swiss-Model at http://expasy.hcuge.ch/swissmod/SWISSMODEL.html; SWISS-PROTat http://expasy.hcuge.ch/sprot/sprottop.html; Threader at http://insulin.brunel.ac.uk/threader/threader.html (accessed Aug 2006).
90. Schulz, G. E.; Schirmer, R. H. Prediction of Secondary Structure from the Amino Acid Sequence. In Principles of Protein Structure; Cantor, C. R., Ed.; Springer-Verlag: New York, 1999, pp 108-130.
91. Wilson, E. K. Chem. Eng. News 2000, Sept 25, 41-4.
92. Holliman, L. Modern Drug Disc. 2000, Nov/Dec, 41-46.
93. Felton, M. J. Modern Drug Disc. 2000, Nov/Dec, 49-54.
94. Vieth, M.; Cummins, D. J. J. Med. Chem. 2000, 43, 3020-3032.
95. Kastenholz, M. A.; Pastor, M.; Cruciani, G.; Haaksma, E.; Fox, T J. Med. Chem. 2000, 43, 3033-3044.
96. Karet, G. Drug Disc. Dev. 2001, Jan, 28-32.
97. Paul Erhardt personal communications while attending several recent scientific conferences in the area of medicinal chemistry.
98. ChemPen 3D at hfevans/chempen.htm; CS Chem Draw and CS Chem Draw 3D at http://www.camsoft.com; Corina at http://www.mol-net.de (accessed Aug 2006).
99. Nezlin, A. Chem. News Com. 1999, 9, 24-25.
100. Endres, M. Today's Chem. at Work 1992, Oct, 30-44.
101. Karet, G. Drug Disc. Dev. 2000, Aug/Sept, 42-48.
102. Rogers, R. S. Chem. Eng. News 1999, Apr 26, 17-18.
103. Hansch, C.; Fujita, T J. Am. Chem. Soc. 1964, 86, 1616-1626.
104. Koshland, D. E., Jr.; Neet, K. E. Annu. Rev. Biochem. 1968, 37, 359-10.
105. Belleau, B. Adv. Drug Res. 1965, 2, 89-126.
106. QUANTA (system for determining 3D protein structure from x-http://www.msi.com (accessed Aug 2006).
107. Hajduk, P. J.; Boyd, S.; Nettesheim, D.; Nienaber, V; Severin, J.; Smith, R.; Davidson, D.; Rockway, T; Fesik, S. W J. Med. Chem. 2000, 43, 3862-3866.
108. Tang, K.; Fu, D.-J.; Julien, D.; Braun, A.; Cantor, C. R.; Koster, H. Proc. Natl. Acad. Sei. USA 1999, 96, 10016-10020.
109. Griffey, R. H.; Hofstadler, S. A.; Sannes-Lowery, K. A.; Ecker, D. J.; Crooke, S. T Proc. Natl. Acad. Sei. USA 1999, 96, 10129-10133.
110. Karet, G. Drug Disc. Dev. 2000, Oct, 38-40.
111. Montanari, M. L. C.; Beezer, A. E.; Montanari, C. A.; Pilo-Veloso, D. J. Med. Chem. 2000, 43, 3448-3452.
112. Medek, A.; Hajduk, P. J.; Mack, J.; Fesik, S. W J. Am. Chem. Soc. 2000, 122, 1241-1242.
113. Rouhi, M. Chem. Eng. News 2000, Feb 21, 30-31.
114. Oostenbrink, B. C.; Pitera, J. W; van Lipzig, M.; Meerman, J. H.; van Gunsteren, W F J. Med. Chem. 2000, 43, 4594-4605;
115. Wu, N.; Mo, Y; Gao, J.; Pai, E. F. Proc. Natl Acad. Sci USA 2000, 97, 2017-2022;
116. Warshel, A.; Strajbl, M.; Villa, J.; Florian, J. Biochem. 2000, 39, 14728-14738.
117. Topological Indices and Related Descriptors in QSAR and QSPR; Devillers J., Balaban, A.T., Eds.; Gordon and Breach: Amsterdam, 1999.
118. Wrotnowski, C. Modern Drug Disc. 1999, Nov/Dec, 46-55.
119. Henry, C. M. Chem. Eng. News 2000, Nov 27, 22-26.
120. Wilson, E. K. Chem. Eng. News 2000, Nov 6, 35-39.
121. Boyd, D. B. Modern Drug Disc. 1998, Nov/Dec, 41-48.
122. Paul Erhardt personal communications while visiting several big pharma and while attending recent scientific conferences in the area of medicinal chemistry.
123. Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W L.; Lundell, G. F; Veber, D. F; Anderson, P S.; Chang, R. S. L. et al. J. Med. Chem. 1988, 31, 2235-2246.
124. Patchett, A. A.; Nargund, R. P. Annu. Rep. Med. Chem. 2000, 35, 289-298.
125. Pastor, M.; Cruciani, G.; McLay, I; Pickett, S.; Clementi, S. J. Med. Chem. 2000, 43, 3233-3243.
126. Gnerre, C.; Catto, M.; Leonetti, F; Weber, P.; Carrupt, P.-A.; Altomare, C.; Carotti, A.; Testa, B. J. Med. Chem. 2000, 43, 4747-4758.
127. Wilcox, R. E.; Huang, W H.; Brusniak, M. Y; Wilcox, D. M.; Pearlman, R. S.; Teeter, M. M.; DuRand, C. J.; Wiens, B. L.; Neve, K. A. J. Med. Chem. 2000, 43, 3005-3019.
128. Jayatilleke, P. R. N.; Nair, A. C.; Zauhar, R.; Welsh, W J. J. Med. Chem. 2000, 43, 4446-4451.
129. Carlson, H. A.; Masukawa, K. M.; Rubins, K.; Bushman, F D.; Jorgensen, W L.; Lins, R. D.; Briggs, J. M.; McCammon, J. A. J. Med. Chem. 2000, 43, 2100-2114.
130. Bradley, E. K.; Beroza, P; Penzotti, J. E.; Grootenhuis, P D.; Spellmeyer, D. C.; Miller, J. L. J. Med. Chem. 2000, 43, 2770-2774.
131. Graffner-Nordberg, M.; Marelius, J.; Ohlsson, S.; Persson, A.; Swedberg, G.; Andersson, P; Andersson, S. E.; Aqvist, J.; Hallberg, A. J. Med. Chem. 2000, 43, 3852-3861.
132. Garcia-Nieto, R.; Manzanares, I.; Cuevas, C.; Gago, F J. Med. Chem. 2000, 43, 4367-4369.
133. Vedani, A.; Briem, H.; Dobler, M.; Dollinger, H.; McMasters, D. R. J. Med. Chem. 2000, 43, 4416-4427.
134. Lopez-Rodriguez, M. L.; Morcillo, M. J.; Fernandez, M.; Rosada, M. L.; Pardo, L.; Schaper, K.-J. J. Med. Chem. 2001, 44, 198-207.
135. Wedin, R. Modern Drug Disc. 1999, Sept/Oct, 39-47.
136. Ladd, B. Modern Drug Disc. 2000, Jan/Feb, 46-52.
137. Venkatsubramanian, V. Computer-Aided Molecular Design Using Neural Networks and Genetic Algorithms. In Genetic Algorithms in Molecular Modeling; Devillers, J., Ed.; Academic Press: New York, 1996, pp 35-70.
138. Globus, A. Nanotechnology 1999, 10, 290-299.
139. Studt, T Drug Disc. Dev. 2000, Aug/Sept, 30-36.
140. Resnick, R. Drug Disc. Dev. 2000, Oct, 51-52.
141. Jaen-Oltra, J.; Salabert-Salvador, T.; Garcia-March, F J.; Perez-Gimenez, F; Tohmas-Vert, F J. Med. Chem. 2000, 43, 1143-1148.
142. Bio Reason at http://www.bioreason.com; Columbus Molecular Software (Lead Scope) at http://www.columbus-molecular.com; Daylight Chemical Information Systems at http://www.daylight.com; IBM (Intelligent Miner) at http://www.ibm.com; Incyte (Life Tools and Life Prot) at http://www.incyte.com; Molecular Applications (Gene Mine 3.5.1) at http://www.mag.com; Molecular Simulations at http://www.msi.com; Oxford Molecular (DIVA 1.1) at http://www.oxmol.com; Pangea Systems (Gene World 3.5) at http://www.pangeasystems.com; Pharsight at http://www.pharsight.com; SAS Institute (Enterprise Miner) at http://www.sas.com; SGI (Mine Set 3.0) at http://www.sgi.com; Spotfire (Spotfire Pro 4.0 and Leads Discover) at http://www.spotfire.com; SPSS (Clementine) at http://www.spss.com; Tripos at http://www.tripos.com (accessed Aug 2006).
143. Johnson, M. A.; Gifford, E.; Tsai, C.-C. In Concepts and Applications of Molecular Similarity; Johnson, M. A., Ed.; John Wiley: New York, 1990, pp 289-320.
144. Gifford, E.; Johnson, M.; Tsai, C.-C. J. Comput.-AidedMol. Des. 1991, 5, 303-322.
145. Gifford, E. M.; Johnson, M. A.; Kaiser, D. G.; Tsai, C.-C. J. Chem. Inf. Comput Sei. 1992, 32, 591-599.
146. Gifford, E. M.; Johnson, M. A.; Kaiser, D. G.; Tsai, C.-C. Xenobiotica 1995, 25, 125-146.
147. Gifford, E.M. Applications of Molecular Similarity Methods to Visualize Xenobiotic Metabolism Structure-Reactivity Relationships. Ph.D. Thesis, University of Toledo, Toledo, OH, USA, 1996.
148. Andrews, K. M.; Cramer, R. D. J. Med. Chem. 2000, 43, 1723-1740.
149. Borowski, T.; Krol, M.; Broclawik, E.; Baranowski, T. C.; Strekowski, L.; Mokrosz, M. J. J. Med. Chem. 2000, 43, 1901-1909.
150. Wintner, E. A.; Moallemi, C. C. J. Med. Chem. 2000, 43, 1933-2006.
151. Stoughton, R. B.; Friend, S. H. Nat. Rev. Drug Disc. 2005, 4, 345-350.
152. Prosser, H.; Rastan, S. Trends Biotechnol. 2003, 3, 224-232.
153. Zambrowicz, B. P.; Sands, A. T Nat. Rev. Drug Disc. 2003, 2, 38-51.
154. Harris, S. Drug Disc. Today 2001, 6, 628-636.
155. Zambrowicz, B. P.; Sands, A. Drug Disc. Today: Targets 2004, 198-207.
156. Elbashir, S. M.; Harborth, J.; Lendeckel, W; Yalcin, A.; Weber, K.; Tuschl, T Nature 2001, 4, 494-498.
157. Dorsett, Y; Tuschl, T Nat. Rev. Drug Disc. 2004, 3, 318-329.
158. Lindvall, J. M.; Blomberg, K.; Emelie, M.; Vaeliaho, J.; Vargas, L.; Heinonen, J. E.; Bergloef, A; Mohamed, A. J.; Nore, B. F; Vihinen, M. et al. Immunol. Rev. 2005, 203, 200-215.
159. Lapteva, N.; Yang, A.-G.; Sanders, D. E.; Strube, R. W.; Chen, S.-Y Cancer Gene Ther. 2005, 12, 84-89.
160. Li, S.-L.; Dwarakanath, R. S.; Cai, Q.; Lanting, L.; Natarajan, R. J. Lipid Res. 2005, 46, 220-229.
161. Aza-Blanc, P.; Cooper, C. L.; Wagner, K.; Batalov, S.; Deveraux, Q. L.; Cooke, M. P Mol. Cell 2003, 12, 627-637.
162. Xin, H.; Bernal, A.; Amato, F A.; Pinhasov, A.; Kauffman, J.; Brenneman, D. E.; Derian, C. K.; Andrade-Gordon, P.; Plata-Salaman, C. R.; Ilyin, S. E. J. Biomol. Screen. 2004, 9, 286-293.
163. Harding, M. W; Galat, A.; Uehling, D. E.; Schreiber, S. L. Nature 1989, 341, 758-760.
164. Becker, F; Murthi, K.; Smith, C.; Come, J.; Costa-Roldan, N.; Kaufmann, C.; Hanke, U.; Degenhart, C.; Baumann, S.; Wallner, W et al. Chem. Biol. 2004, 11, 211-223.
165. Bouwmeester, T; Bauch, A.; Ruffner, H.; Angrand, P.-O.; Bergamini, G.; Croughton, K.; Cruciat, C.; Eberhard, D.; Gagneur, J.; Ghidelli, S. et al. Nat. Cell Biol. 2004, 6, 97-105.
166. Colland, F; Jacq, X.; Trouplin, V; Mougin, C.; Groizeleau, C.; Hamburger, A.; Meil, A.; Wojcik, J.; Legrain, P; Gauthier, J.-M. Genome Res. 2004, 14, 1324-1332.
167. Li, S.; Armstrong, C. M.; Bertin, N.; Ge, H.; Milstein, S.; Boxem, M.; Vidalain, P. O.; Han, J.-D. J.; Chesneau, A.; Hao, T et al. Science 2004, 303, 540-544.
168. Mancinelli, R.; Cronin, M.; Sadee, W. Pharma. Sci. 2000, as an electronic reference.
169. Robert, J.; Vekris, A.; Pourquier, P; Bonnet, J. Crit. Rev. Oncol. Hematol. 2004, 51, 205-227.
170. Bugelski, P. J. Curr. Opin. Drug Disc. 2002, 5, 79-89.
171. Samson, M.; Libert, F; Doranz, B. J.; Rucker, J.; Liesnard, C.; Farber, C.-M.; Saragosti, S.; Lapouméroulie, C.; Cognaux, J.; Forceille, C. et al. Nature 1996, 382, 722.
172. Mullin, R. Chem. Eng. News 2005, Feb 28, 29-39 (Based upon original data provided by the Center for Medicines Research International, IMS Health).
173. Hegde, S.; Carter, J. Annu. Rep. Med. Chem. 2004, 39, 337-368.
174. Handen, J. S. Drug Disc. Today 2002, 7, 83-85;
175. Van de Waterbeemd, H. Curr. Opin. Drug Disc. Dev. 2002,5, 33-3;
176. Chanda, S. K.; Cal dwell, J. S. Drug Disc. Today 2003, 8, 168-174;
177. Drews, J. Drug Disc. Today 2003, 8, 411-20;
178. FDA. FDA White Paper 2004;
179. Van den Haak, E. A. CMR Report 2004, 04-234R.
180. Sams-Dodd, F. Drug Disc. Today 2005, 10, 139-147.
181. Harness, J. In Innovations in Pharmaceutical Technology; Barnacal, P. A., Ed.; Chancery Media: London, 2000, pp 37-45.
182. Boguslavsky, J. Drug Disc. Dev. 2000, Aug/Sept, 51-54.
183. Boguslavsky, J. Drug Disc. Dev. 2000, Oct, 54-58.
184. Gibson, J.; Karet, G. Drug Disc. Dev. 2000, June/July, 61-64.
185. Paul Erhardt personal communications during the 175th Anniversary USP Convention held in Washington, DC: March, 1995.
186. Green Chemistry: Frontiers in Benign Chemical Syntheses and Processes; Anastas, P, Williamson, T C., Eds.; Oxford University Press: Cary, NC, 1998.
187. Anastas, P; Warner, J. Green Chemistry: Theory and Practice; Oxford University Press: Cary, NC, 1998.
188. Green Chemical Syntheses and Process (Part 1) and Green Engineering (Part 2); Anastas, P. T, Heine, L. G., Williamson, T. C., Eds.; Oxford University Press: Cary, NC, 2000.
189. Green Chemistry: Challenging Perspectives; Tundo, P, Anastas, P, Eds.; Oxford University Press: Cary, NC, 2000.
190. Stinson, S. C. Chem. Eng. News 2000, Oct 23, 55-78.
191. Auclair, K.; Sutherland, A.; Kennedy, J.; Witter, D. J.; Van den Heever, J. P; Hutchinson, C. R.; Vederas, J. C. J. Am. Chem. Soc. 2000, 122, 11519-11520.
192. Watanabe, K.; Oikawa, H.; Yagi, K.; Ohashi, S.; Mie, T; Ichihara, A.; Honma, M. J. Biochem. 2000, 127, 467-73.
193. Watanabe, K.; Mie, T.; Ichihara, A.; Oikawa, H.; Honma, M. J. Biol. Chem. 2000, 275, 38393-38401.
194. Borman, S. Chem. Eng. News 2001, Jan 15, 9.
195. Yalkowski, S. H.; Valvani, S. C. J. Pharm. Sei. 1980, 69, 912-922.
196. Mason, R. P; Rhodes, D. G.; Herbette, L. G. J. Med. Chem. 1991, 34, 869-877.
197. Herbette, L. G.; Rhodes, D. G.; Mason, R. P. Drug Des. Deliv. 1991, 7, 75-118.
198. Abraham, M. H.; Chada, S.; Mitchell, R. J. Pharm. Sei. 1994, 83, 1257-1268.
199. Basak, S. C.; Gute, B. D.; Drewes, L. R. Pharm. Res. 1996, 13, 775-778.
200. Kansy, M.; Senner, F; Gubernator, K. J. Med. Chem. 1998, 41, 1007-1010.
201. Palm, K.; Luthman, K.; Ungell, A.-L.; Strandlund, G.; Beigi, F; Lundahl, P.; Artursson, P. J. Med. Chem. 1998, 41, 5382-5392.
202. Smith, D. A.; Van de Waterbeemd, H. Curr. Opin. Chem. Biol. 1999, 3, 373-378.
203. Stewart, B. H.; Wang, Y; Surendran, N. Annu. Rep. Med. Chem. 2000, 35, 299-307.
204. Crivori, P; Cruciani, G.; Carrupt, P-A.; Testa, B. J. Med. Chem. 2000, 43, 2204-2216.
205. Yoshida, F; Topliss, J. G. J. Med. Chem. 2000, 43, 2575-2585.
206. Lombardo, F; Shalaeva, M. Y; Tupper, K. A.; Gao, F; Abraham, M. H. J. Med. Chem. 2000, 43, 2922-2928.
207. Ertl, P; Rohde, B.; Selzer, P. J. Med. Chem. 2000, 43, 3714-3717.
208. Egan, W J.; Merz, K. M., Jr.; Baldwin, J. J. J. Med. Chem. 2000, 43, 3867-3877.
209. Chait, A. Drug Disc. Dev. 2000, Apr, 63.
210. Pickering, L. Drug Disc. Dev. 2001, Jan, 34-38.
211. Absorption Systems 'BCS Biowaivers' at http://www.absorption.com; ArQule 'Pilot' at http://www.argule.com; Camitro Corp. ADME/Tox' at http://www.camitro.com; Cerep SA'BioPrints' at http://www.cerep.fr; Exon Hit Therapeutics SA'Genetic Makeup/Drug Toxicity' at http://www.exonhit.com; LION Bioscience AG 'i-Biology at SRS databases' at http://www.lionbioscience.com; Quintiles 'Early ADMET Screening' at qkan.busdev@quintiles.com; Schrodinger, Inc. 'QikProp' at http://www.schrodiner.com; Simulations Plus 'GastroPlus' at http://www.simulationsplus.com; Trega Biosciences 'In vitro ADME' at http://www.trega.com (accessed Aug 2006).
212. Transport Processes in Pharmaceutical Systems; Amidon, G. L., Lee, PI., Topp, E. M., Eds.; Marcel Dekker: New York, 1999.
213. Membrane Structure in Disease and Drug Therapy; Zimmer, G., Ed.; Marcel Dekker: New York, 2000.
214. Oral Drug Absorption: Prediction and Assessment; Dressman, J. B., Lennernas, H., Eds.; Marcel Dekker: New York, 2000.
215. Taylor, E. W; Gibbons, J. A.; Braeckman, R. A. Pharm. Res. 1997, 14, 572-577.
216. Gibbons, J. A.; Taylor, E. W; Dietz, C. M.; Luo, Z.-P; Luo, H.; Braeckman, R. A. High-Throughput Screening for Gastrointestinal Absorption in the Generation of SAR Databases. In Drug Metabolism: Databases and High Throughput Testing during Drug Design and ; Erhardt, P. W, Ed.; IUPAC/Blackwell Science: Oxford, 1999, pp 71-78.
217. Rouhi, M. Chem. Eng. News 2001, Jan 29, 10.
218. Janout, V; DiGiorgio, C.; Regen, S. L. J. Am. Chem. Soc. 2000, 122, 2671-2672.
219. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T; Steinman, L.; Rothbard, J. B. Proc. Natl. Acad. Sei. USA 2000, 97, 13003-13008.
220. Rothbard, J. B.; Garlington, S.; Lin, Q.; Kirschberg, T; Kreides, E.; McGrove, P. L.; Wendy, P A.; Kharari, P. A. Nat. Med. 2000, 6, 1253-1257.
221. Henry, C. M. Chem. Eng. News 2000, Oct 23, 85-100.
222. Rouhi, M. Chem. Eng. News 2000, Sept 4, 43.
223. Dagani, R. Chem. Eng. News 2000, Oct 16, 27-32.
224. Schulz, W. Chem. Eng. News 2000, Oct 16, 39-42.
225. Zurer, P. Chem. Eng. News 2001, Mar 12, 12.
226. Controlled Drug Delivery; Park, K., Mrsny, R. J., Eds.; American Chemical Society: Washington, DC, 2000.
227. Mort, M. Med. Drug Disc. 2000, Apr, 30-34.
228. Henry, C. M. Chem. Eng. News 2000, Sept 18, 49-65.
229. Bracht, S. Innov. Pharm. Tech. 2000, 5, 92-98.
230. Levy, A. Innov. Pharm. Tech. 2000, 5, 100-109.
231. Southall, J.; Ellis, C. Innov. Pharm. Tech. 2000, 5, 110-115.
232. Winnips, C.; Keller, M. Innov. Pharm. Tech. 2000, 6, 70-75.
233. Winnips, C. Drug Disc. World 2000/2001, 2, 62-66.
234. Watkins, K. J. Chem. Eng. News 2000, Jan 8, 11-15.
235. Jacoby, M. Chem. Eng. News 2001, Feb 5, 30-35.
236. Lipinski, C. A.; Lombardo, F; Dominy, B. W; Feeney, P. J. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
237. Erhardt, P. W Metabolism Prediction. In High-Throughput ADMETox Estimation: In vitro and In Silico ; Darvas, F, Dorman, G., Eds.; BioTechniques Press/Easton Publication: Westborough, MA, 2002, pp 41-48.
238. Frostell-Karlsson, A.; Remaeus, A.; Roos, H.; Andersson, K.; Borg, P.; Hamalainen, M.; Karlsson, R. J. Med. Chem. 2000, 43, 1986-1992.
239. Diaz, N.; Suarez, D.; Sordo, T. L.; Merz, K. M., Jr. J. Med. Chem. 2001, 44, 250-260.
240. Hajduk, P. J.; Bures, M.; Praestgaard, J.; Fesik, S. W. J. Med. Chem. 2000, 43, 3443-3447.
241. Czech, M. P. Chem. Ind. Inst. Tox. Activities 2000, May/June, 2-4.
242. Dechantsreiter, M. A.; Planker, E.; Matha, B.; Lohof, E.; Holzemann, G.; Jonczyk, A.; Goodman, S. L.; Kessler, H. J. Med. Chem. 1999, 42, 3033-3040.
243. Pasqualini, R.; Koivunen, E.; Kain, R.; Lahdenranta, J.; Sakamoto, M.; Stryhn, A.; Ashmun, R. A.; Shapiro, L. H.; Arap, W; Ruoslahti, E. Cancer Res. 2000, 60, 722-727.
244. Eberhard, A.; Kahlert, S.; Goede, V; Hemmerlein, B.; Plate, K. H.; Augustin, H. G. Cancer Res. 2000, 60, 1388-1393.
245. Wyder, L.; Vitaliti, A.; Schneider, H.; Hebbard, L. W.; Moritz, D. R.; Wittmer, M.; Ajmo, M.; Klemenz, R. Cancer Res. 2000, 60, 4682-4688.
246. Matsuda, M.; Nishimura, S.-I.; Nakajima, F; Nishimura, T. J. Med. Chem. 2001, 44, 715-724.
247. Metzger, T G.; Paterlini, M. G.; Portoghese, P. S.; Ferguson, D. M. Neurochem. Res. 1996, 21, 1287-1294.
248. Larson, D. L.; Jones, R. M.; Hjorth, S. A.; Schwartz, T W; Portoghese, P S. J. Med. Chem. 2000, 43, 1573-1576.
249. Marx, J. L. Science 1982, 216, 283-285.
250. Baeuerle, P. A.; Wolf, E. Modern Drug Disc. 2000, Apr, 37-42.
251. Geelhoed, G. W. S. Afr. J. Surg. 1988, 26, 1-3.
252. Ehrlich, P. Lancet 1913, 445-451.
253. Albert, A. Selective Toxicity; John Wiley: New York, 1960.
254. Prodrugs as Novel Drug Delivery Systems; Higuchi, T, Stella, V, Eds.; American Chemical Society: Washington, DC, 1975;
255. Design of Prodrugs; Bundgaard, H., Ed.; Elsevier: Amsterdam, 1985.
256. Bodor, N. In Strategy in Drug Research; Buisman, J. A. K., Ed.; Elsevier: Amsterdam, the Netherlands, 1982, pp 137-164.
257. Bodor, N.; Buchwald, P. Med. Res. Rev. 2000, 20, 58-101.
258. Rozman, K. K.; Klaassen, C. D.; Parkinson, A.; Medinsky, M. A.; Valentine, J. L. Dispositon of Toxicants. In Casarett & Doull's Toxicology: The Basic Science of Poisons, 6th ed.; Klaassen, C. D., Ed.; McGraw-Hill: New York, 2001, pp 105-237.
259. Drug Metabolism: Databases and High-Throughput Screening during Drug Design and Development; Erhardt, P., Ed.; IUPAC/Blackwell Science: London, 1999.
260. Handbook of Drug Metabolism; Woolf, T, Ed.; Marcel Dekker: New York, 1999.
261. Guengerich, F P. Cytochrome P450 Enzymes. In Biotransformation, Vol. 3, Comprehensive Toxicology; Guengerich, F P., Ed.; Elsevier Science: Oxford, 1997, pp 37-68.
262. Satoh, T; Hosokawa, M. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 257-288.
263. Sarver, J.; White, D.; Erhardt, P; Bachmann, K. Envir. Health Perspect. 1997, 105, 1204-1209.
264. Ward, K. W; Erhardt, P; Bachmann, K. J. Pharmacol. Toxicol. Methods 2005, 51, 57-64.
265. Darvas, F Metabol Expert: An Expert System for Predicting the Metabolism of Substances. In OSAR in Environmental Toxicology II; Kaiser, C., Ed.; Reidel: Dordrecht, 1987, pp 71-81.
266. Klopman, G.; Dimayuga, M.; Talafous, J. J. Chem. Inf. Comput. Sci. 1994, 34, 1320-1325.
267. Gifford, E.; Johnson, M.; Tsai, C. Molecular Connection: The MDL Newsletter for Communicating with Customers 1994, 13, 12-13.
268. Biotransformations, 1-7; Hawkins, D., Ed.; Royal Society of Chemistry: Cambridge, 1997 (first database release).
269. Greene, N. Knowledge Based Expert Systems for Toxicity and Metabolism Prediction. In Drug Metabolism: Databases and High Throughput Testing during Drug Design and Development; Erhardt, P, Ed.; IUPAC Blackwell Science: London, 1999, pp 289-296.
270. Erhardt, P. J. Curr. Drug Metab. 2003, 4, 411-422.
271. Thompson, E. A.; Siiteri, P. K. J. Biol. Chem. 1974, 249, 5373.
272. Fishman, J.; Goto, J. J. Biol. Chem. 1981, 256, 4466.
273. Metcalf, B. W. J. Am. Chem. Soc. 1981, 103, 3221.
274. Marcotte, P; Robinson, C. H. Biochemistry 1982, 21, 2773.
275. Covey, D. V J. Biol. Chem. 1983, 256, 1076.
276. Erhardt, P. Abstract Soc. Tox. Canada 32nd Annual Symposium, Montreal, 1999.
277. Sina, J. F. Annu. Rep. Med. Chem. 1998, 33, 283-291.
278. Conolly, R. B. Chem. Industry Inst. Tox. Activities 1999, 19, 6-8.
279. Jacobs, M. Chem. Eng. News 2000, Mar 13, 29.
280. Boguslavsky, J. Drug Disc. Dev. 2000, June/July, 43-46.
281. Eggers, M. Innov. Pharm. Tech. 2000, 6, 36-44.
282. Boguslavsky, J. Drug Disc. Dev. 2000, Oct, 30-36.
283. Neft, R. E.; Farr, S. Drug Disc. World 2000, 1 (2), 33-34.
284. For general toxicology: Cellomics, Inc. at http://www.cellomics.com; Celera, Inc. at http://www.celera.com; Chemical Industry Inst. Tox. at http://www.ciit.org; Inpharmatica at http://www.inpharmatica.co.uk; Nat. Ctr. Bioinformatics at http://www.ncbi.nlm.nih.gov/Web/Genebank/index.html and at http://www.ncbi.nlm.nih.gov/Entvez/Genonome/org.html; Rosetta Inpharmatics at http://www.vii.com; SciVision (ToxSYS) at http://www.scivision.com. For drug-drug interactions: Georgetown Univ. at http://dml.Georgetown.edu/depts/pharmacology/clinlist.html; FDA at http://www.fda.gov/cder/drug/advisory/stjwort.htm; Public Citizen Health Research Group at http://www.citizen.org/hrg/newsletters/pillnews.htm (accessed Aug 2006).
285. Kuypu, B. J. Chem. Ind. Inst. Tox. Activities 2000, 20, 1-2.
286. Henry, C. J.; Bus, J. S. Chem. Ind. Inst. Tox. Activities 2000, 20, 1-5.
287. Felton, M. J. Modern Drug Disc. 2000, Oct, 81-83.
288. Hogue, C. Chem. Eng. News 2001, Mar 19, 33-34.
289. Lewalle, P. Terminol. Stand. Harmon. 1999, 11, 1-28.
290. Duffus, J. H. Chem. Int. (IUPAC News Magazine) 2001, 23, 34-39.
291. Klopman, G. Quant. Struct.-Act. Relat. 1992, 11, 176-184.
292. Willis, R.; Felton, M. J. Modern Drug Disc. 2001, Jan, 31-36.
293. Sanderson, D.; Earnshaw, C.; Judson, P. Hum. Expt. Tox. 1991, 10, 261-273.
294. Gad, S. C. SciVision Update 2001, Jan, 1-2.
295. Neft, R. E.; Farr, S. Drug Disc. World 2000, Feb, 33-34.
296. Wood, F. Natural Cures and Gentle Medicines that Work Better than Dangerous Drugs or Risky Surgery. Newspaper advertisement, The Blade (Toledo, OH) 2000, Jan 25, p 3A.
297. Howe, K. Scientists Rip Herbal Remedies Fatal Health Problems Tied to Lack of Regulation. San Francisco Chronicle, 2000, Jan 21, p 5.
298. Barnes, J. A Inpharma 1999, 1185, 1.
299. Keung, W-M.; Lazo, O.; Kunze, L.; Vallee, B. Proc. Natl. Acad. Sei. USA 1996, 93, 4284-4289.
300. Stermitz, F; Lorenz, P; Tawara, J.; Zenewicz, L.; Lewis, K. Proc. Natl. Acad. Sci. USA 2000, 97, 1433-1438.
301. Guz, N. R.; Stermitz, F. R. J. Nat. Prod. 2000, 63, 1140-1145.
302. Keung, W M.; Lazo, O.; Kunze, L.; Vallee, B. L. Proc. Natl. Acad. Sci. USA 1995, 92, 8990-8993.
303. Verma, S.; Salamone, E.; Goldin, B. Biochem. Biophys. Res. Commun. 1997, 233, 692-696.
304. Mammen, M.; Choi, S. K.; Whitesides, G. M. Angew. Chem. Int. Ed. Engl. 1998, 10, 2754-2794.
305. Kiessling, L. L.; Strong, L. E.; Gestwicki, J. E. Annu. Rep. Med. Chem. 2000, 35, 321-330.
306. Annoura, H.; Nakanishi, K.; Toba, T; Takemoto, N.; Imajo, S.; Miyajima, A.; Tamura-Horikawa, Y; Tamura, S. J. Med. Chem. 2000, 43, 3372-3376.
307. Gangjee, A.; Yu, J.; McGuire, J. J.; Cody, V; Galitsky, N.; Kisliuk, R. L.; Queener, S. F J. Med. Chem. 2000, 43, 3837-3851.
308. Borman, S. Chem. Eng. News 2000, Oct 9, 48-53.
309. Sucheck, S. J.; Wong, A. L.; Koeller, K. M.; Boehr, D. D.; Draker, K.; Sears, P.; Wright, G. D.; Wong, C.-H. J. Am. Chem. Soc 2000, 122, 5230-5231.
310. Faghihi, J.; Jiang, X.; Vierling, R.; Goldman, S.; Sharfstein, S.; Sarver, J.; Erhardt, P. J. Chromatogr., A 2001, 915, 61-74.
311. Brun, Y; Wrzossek, C.; Parsons, J.; Slocum, H.; White, D.; Greco, W Am. Assoc. Cancer Rßs. Proc. 2000, 41, 102 (abstract).
312. White, D.; James, L. J. Clin. Epidemiol. 1996, 49, 419-429.
313. Greco, W; Bravo, G.; Parsons, J. Pharmacol. Rev. 1995, 47, 331-385.
314. Faessel, H. M.; Slocum, H. K.; Rustum, Y M.; Greco, W R. Biochem. Pharmacol. 1999, 57, 567-577.
315. Paired agent combinations = 100!/(2! 98!) = 4950 agent pairs. Test each pair at 3 concentrations for each agent = 9 combinations per pair. Number of pair tests = 9 (4950) = 44550. Number of single agent tests at 3 concentrations per agent = 3(100) = 300. Total tests for an N = 1 pass through library = 44 550 + 300 = 44 850.
316. Moos, W.; Green, G. D.; Pavia, M. R. Annu. Rep. Med. Chem. 1993, 28, 315-324.
317. Spellmeyer, D. C.; Grootenhuis, P. D. J. Annu. Rep. Med. Chem. 1999, 34, 287-296.
318. Dorfman, A. Time 2001, July 1, 97-99.
319. Huang, J.-S.; Barker, K. Plant Physiol. 1991, 96, 1302-1307.
320. Cheong, J. J.; Alba, R.; Cote, F; Enkerli, J.; Hahn, M. G. Plant Physiol 1993, 103, 1173-1182.
321. Organic Chemistry of Secondary Plant Metabolism; Geissman, T, Crout, D., Eds.; Freeman, Cooper and Co.: San Francisco, CA, 1969.
322. The Biosynthesis of Secondary Metabolites; Herbert, R., Ed.; Chapman and Hall: New York, 1989.
323. Murashige, T; Skoog, F Physiol. Plant 1962, 15, 473-497.
324. Borman, S. Chem. Eng. News 2000, Oct 30, 35-36.
325. Gruber, V; Theisen, M. Annu. Rep. Med. Chem. 2000, 35, 357-364.
326. Erhardt, P. W Epilogue. In Drug Metabolism: Databases and High-Throughput Testing During Drug Design and ; Erhardt, P. W, Ed.; IUPAC/Blackwell Science: London, 1999, p 320.
327. Hehre, W J.; Radom, L.; Schleyer, P. van R.; Pople, J. A. Ab Initio Molecular Orbital ; John Wiley: New York, 1986.
328. Becke, A. D. J. Chem. Phys. 1993, 98, 5648-5652.
329. Hu, Z. M.S. Thesis, University of Toledo, Toledo, OH, USA, 1997.
330. Hu, Z.; Erhardt, P. W. Org. Proc. Res. Dev. 1997, 1, 387-390.
331. Hu, Z.; Hardie, M. J.; Burckel, P.; Pinkerton, A. A.; Erhardt, P.W J. Chem. Crystallogr. 1999, 29, 185-191.
332. Marchand, A. P; Wang, Y; Ren, C.-T; Vidyasagar, V; Wang, D. Tetrahedron 1996, 52, 6063-6072.
333. Pomerantz, M.; Hartman, P. H. Tetrahedron Lett. 1968, 10, 991-993.
334. Turro, N. J.; Wriede, P. A. J. Am. Chem. Soc. 1970, 92, 320-329.
335. Lewis, F D.; Turro, N. J. J. Am. Chem. Soc. 1970, 92, 311-320.
336. Friedrich, L. E.; Lam, P Y-S. J. Org. Chem. 1981, 46, 306-311.
337. Klis, W A.; Erhardt, P W Synthet. Commun. 2000, 30, 4027-4038.
338. Erhardt, P. W; Klis, W A.; Nagy, P. I.; Kirschbaum, K.; Wu, N.; Martin, A.; Pinkerton, A. A. J. Chem. Crystallogr. 2000, 30, 83-90.
339. Erhardt, P.; Klis, W US Patent 6, 255,540, 2001.
340. Endicott, J. A.; Ling, V Annu. Rev. Biochem. 1989, 58, 137-171.
341. Gottesman, M. M.; Pastan, I. Annu. Rev. Biochem. 1993, 62, 385-427.
342. Scheffer, G. L.; Kool, M.; Heijn, M.; deHaas, M.; Pijnenborg, A.; Wijnholds, J.; van Helvoort, A.; de Jong, M. C.; Hooijberg, J. H.; Mol, C. et al. Cancer Res. 2000, 60, 5269-5277.
343. Allen, J. D.; Brinkhuis, R. F; van Deemter, L.; Wijnholds, J; Schinkel, A. Cancer Res. 2000, 60, 5761-5766.
344. Multidrug Resistance in Cancer Cells: Molecular, Biochemical, Physiological and Biological Aspects; Gupta, S., Tsuruo, T, Eds.; John Wiley: Chichester, UK, 1996.
345. Moscow, J. A.; Schneider, E.; Ivy, S. P.; Cowan, K. H. Cancer Chemother. Biol. Resp. Modif. 1997, 17, 139-177.
346. Gottesman, M. M.; Pastan, I.; Ambudkar, S. V. Curr. Opin. Genet. Dev. 1996, 6, 610-617.
347. Gros, P; Croop, J.; Housman, D. Cell 1986, 47, 371-380.
348. Cole, S. P; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U; Duncan, A. M.; Deeley, R. G. Science 1992, 258, 1650-1654.
349. Doyle, L. A.; Yang, W; Abruzzo, L. V; Krogmann, T; Gao, Y; Rishi, A. K.; Ross, D. D. Proc. Natl. Acad. Sei. USA 1998, 95, 15665-15670.
350. Ramachandran, C.; Melnick, S. J. Mol. Diagn. 1999, 4, 81-94.
351. Values reported in the NIH/NCI database at http://dtp.nci.nih.gov/docs/cancer/searches/standardmechanismlist.html#topo1. Similar values are obtained in our labs using MCF-7 versus NCI/ADR-RES cell lines (unreported data).
352. Wall, M. E. Camptothecin and Taxol. In Chronicles of Drug Discovery; Lednicer, D., Ed.; American Chemical Society: Washington, DC, 1993, pp 327-348.
353. Suffness, M. Annu. Rep. Med. Chem. 1993, 28, 305-314.
354. George, G.; Ali, S. M.; Zygmunt, J.; Jayasinghe, L. R. Exp. Opin. Ther. Patents 1994, 4, 109-120.
355. Nicolaou, K. C.; Dai, W-M.; Guy, R. K. Angew. Chem. Int. Ed. Engl. 1994, 33, 15-44.
356. Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T, Ojima, I., Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995.
357. Sonneveld, P.; Wiemer, E. Cur. Opin. Oncol. 1997, 9, 543-548.
358. Ling, V. Cancer Chemother. Pharmacol. 1997, 40, S3-S8.
359. Fisher, G. A.; Sikic, B. I. Hematol. Oncol. Clin. N. Am. 1995, 9, 363-382.
360. Sarver, J.; Erhardt, P.; Klis, W; Byers, J. Abstract, SGK 2000 Reaching for the Cure/Making a Difference Mission Conference 2000.
361. Kingsbury, W D.; Boehm, J. C.; Jakas, D. R.; Holden, K. G.; Hecht, S. M.; Gallagher, G.; Caranfa, M. J.; McCabe, F L.; Faucette, L. F; Johnson, R. K. et al. J. Med. Chem. 1991, 34, 98-107.
362. Liu, L. Adv. Pharmacol. 1994, 29B, 1-298.
363. Sinha, B. Drugs 1995, 49, 11-19.
364. Pantazis, P; Giovanella, B.; Rothenberg, M. Ann. N'T Acad. Sei. 1996, 803, 1-328.
365. Jaxel, C.; Kohn, K.; Wani, M.; Wall, M.; Pommier, Y Cancer Res. 1989, 49, 1465-1469.
366. Wall, M.; Wani, M.; Nicholas, A.; Manikumar, G.; Tele, C.; Moore, L.; Truesdale, A.; Leitner, P; Besterman, J. J. Med. Chem. 1993, 36, 2689-2700.
367. Pommier, Y. Semin. Oncol. 1996, 23, 3-10.
368. Wall, M.; Wani, M. Ann. NY Acad. Sei. 1996, 803, 1-12.
369. Uehling, D.; Nanthakumar, S.; Croom, D.; Emerson, D.; Leitner, P; Luzzio, M.; McIntyre, G.; Morton, B.; Profeta, S.; Sisco, J. et al. J. Med. Chem. 1995, 38, 1106-1118.
370. Sawada, S.; Matsuoka, S.; Nokata, K.; Nagata, H.; Furuta, T; Yokokura, T.; Miyasaka, T Chem. Pharm. Bull. 1991, 39, 3183-3188.
371. Sugimori, M.; Ejima, A.; Ohsuki, S.; Uoto, K.; Mitsui, I.; Matsumoto, K.; Kawato, Y; Yasuoka, M.; Sato, K.; Tagawa, H. et al. J. Med. Chem. 1994, 37, 3033-3039.
372. Giovanella, B.; Stehlin, J.; Wall, M.; Wani, M.; Nicholas, A.; Liu, L.; Silber, R.; Potmesil, M. Science 1989, 246, 1046-1048.
373. Hinz, H.; Harris, N.; Natelson, E.; Giovanella, B. Cancer Res. 1994, 54, 3096-3100.
374. Wang, H.; Liu, S.; Hwang, K.; Taylor, G.; Lee, K.-H. Bioorg. Med. Chem. 1994, 2, 1397-1402.
375. Luzzio, M.; Besterman, J.; Emerson, D.; Evans, M.; Lackey, K.; Leitner, P; McIntyre, G.; Morton, B.; Myers, P; Peel, M. et al. J. Med. Chem. 1995, 38, 395-401.
376. Lackey, K.; Besterman, J.; Fletcher, W; Leitner, P.; Morton, B.; Sternbach, D. J. Med. Chem. 1995, 38, 906-911.
377. Lackey, K.; Sternbach, D.; Croom, D.; Emerson, D.; Evans, M.; Leitner, P; Luzzio, M.; McIntyre, G.; Vuong, A.; Yates, J. et al. J. Med. Chem. 1996, 39, 713-719.
378. Nicholas, A.; Wani, M.; Manikumar, G.; Wall, M.; Kohn, K.; Pommier, Y J. Med. Chem. 1990, 33, 972-978.
379. Crow, R.; Crothers, D. J. Med. Chem. 1992, 35, 4160-4164.
380. Jaxel, C.; Kohn, K. W; Wani, M. C.; Wall, M. E.; Pommier, Y Cancer Res. 1989, 49, 1465-1469.
381. Pommier, Y; Jaxel, C.; Heise, C. Structure-Activity Relationship of Topoisomerase I Inhibition by Camptothecin Derivatives: Evidence for the Existence of a Ternary Complex. In DNA Topoisomerases in Cancer; Potmesil, M., Kohn, K., Eds.; Oxford University Press: New York, 1991, pp 121-132.
382. Lackey, K.; Besterman, J.; Fletcher, W; Leitner, P.; Morton, B.; Sternbach, D. J. Med. Chem. 1995, 38, 906-911.
383. Sugimori, M.; Ejima, A.; Ohsuki, S.; Uoto, K.; Mitsui, I.; Matsumoto, K.; Kawato, Y; Yasuoka, M.; Sato, K.; Tagawa, H. et al. J. Med. Chem. 1994, 37, 3033-3039.
384. Carrigan, S.; Fox, P; Wall, M.; Wani, M.; Bowen, J. J. Comput.-AidedMol. Des. 1997, 11, 71-78.
385. Rodi, D. J.; Janes, R. W; Sanganee, H. J.; Holton, R. A.; Wallace, B. A.; Makowski, L. J. Mol. Biol. 1999, 285, 197-203.
386. Yang, C.-P; Horwitz, S. B. Cancer Res. 2000, 60, 5171-5178.
387. Andre, N.; Braguer, D.; Brasseur, G.; Goncalves, A.; Lemesle-Meunier, D.; Guise, S.; Jordan, M. A.; Briand, D. Cancer Res. 2000, 60, 5349-5353.
388. Schiff, P. B.; Fant, J.; Horwitz, S. B. Nature 1979, 277, 665-667.
389. Erhardt, P. W Taxane J. 1997, 3, 36-42.
390. Nakashio, A.; Fujita, N.; Rokudai, S.; Sato, S.; Tsuruo, T Cancer Res. 2000, 60, 5303-5309.
391. Froelich-Ammon, S.; Osheroff, N. J. Biol. Chem. 1995, 270, 21429-21432.
392. Klis, W; Sarver, J.; Erhardt, P. Synthet. Commun. 2002, 32, 2711-2718.
393. Klis, W; Sarver, J.; Erhardt, P. Tetrahedron Lett. 2001, 42, 7747-7750.
394. Klis, W; Sarver, J.; Erhardt, P. US Patent, 6,846,937, B2, 2005.
395. Erhardt, P. Chron. Drug Disc. 1993, 3, 191-206.
396. Erhardt, P. W; Woo, C. M.; Gorczynski, R. J.; Anderson, W G. J. Med. Chem. 1982, 25, 1402-1407.
397. Erhardt, P. W; Woo, C. M.; Anderson, W G.; Gorczynski, R. J. J. Med. Chem. 1982, 25, 1408-1412.
398. Erhardt, P. W; Woo, C. M.; Matier, W L.; Gorczynski, R. J.; Anderson, W G. J. Med. Chem. 1983, 26, 1109-1112.
399. Erhardt, P. W. US Patent, 6,750,238 B1, 2004.
400. Erhardt, P. W. US Patent, 6,756,047 B2, 2004.
401. Liao, J.; Golding, K.; Dubischar, K.; Sarver, J.; Erhardt, P; Kuch, H.; Aouthmany, M. Abstract, 27th National ACS Medicinal Chemistry Symposium, 2000.
402. Liao, J. M.S. Thesis, University of Toledo, Toledo, OH, USA, 2000.
403. Pattisal, K. H. Discovery and Development of Zidovudine. In The Search for Antiviral Drugs; Adams, J. A., Merluzzi, J., Eds.; Birkhauser: Boston, MA, 1993, pp 23-43.
404. Horwitz, J. P.; Chua, J.; Noel, M. J. Org. Chem. 1964, 29, 2076-2078.
405. Mitsuya, H.; Weinhold, K. J.; Furman, P. A.; St. Clair, M. H.; Nusinoff Lehrman, S.; Gallo, R. C.; Bolognesi, D.; Barry, D. W; Broder, S. Proc. Natl. Acad. Sci. USA 1985, 82, 7096-7100.
406. Horwitz, J. P; Chua, J.; Da, M.; Rooge, A.; Noel, M. Tetrahedron Lett. 1964, 5, 2725-2727; J. Med. Chem. 1987,30, 440-444;
407. Lin, T S.; Schinazi, R. F; Prusoff, W. H. Biochem. Pharmacol. 1987, 36, 2713-2718.
408. Horwitz, J. P.; Chua, J.; Noel, M.; Donatti, J. T. J. Org. Chem. 1967, 32, 817-818.
409. Thormar, H.; Balzarini, J.; Holy, A.; Jindrich, J.; Rosenberg, I.; Debyser, Z.; Desmyter, J.; De Clercq, E. Antimicrob. Agents Chemother. 1993, 37, 2540-2544.
410. Robbins, B. L.; Srinivas, R. V; Kim, C.; Bischofberger, N.; Fridland, A. Antimicrob. Agents Chemother. 1998, 42, 612-617.
411. Tuske, S.; Sarafianos, S. G.; Clark, A. D.; Ding, J.; Naeger, L. K.; White, K. L.; Miller, M. D.; Gibbs, C. S.; Boyer, P. L.; Clark, P. et al. Nat. Struct. Mol. Biol. 2004, 11, 469-474.
412. Larder, B. A.; Kemp, S. D. Science 1989, 246, 1155-1158.
413. Roberts, J. D.; Bebenek, K.; Kunkel, T A. Science 1988, 242, 1171-1173;
414. B. D.; Poiesz, B. J.; Loeb, L. A. Science 1988, 242, 1168-1171.
415. Lewis, W. Progr. Cardiovasc. Dis. 2003, 45, 305-318.
416. Merluzzi, V J.; Hargrave, K. D.; Labadia, M.; Grozinger, K.; Skoog, M.; Wu, J. C.; Shih, C. K.; Eckner, K.; Hattox, S.; Adams, J. et al. Science 1990, 250, 1411-1413.
417. Dueweke, T. J.; Poppe, S. M.; Romero, D. L.; Swaney, S. M.; So, A. G.; Downey, K. M.; Althaus, I. W; Reusser, F; Busso, M.; Resnick, L. Antimicrob. Agents Chemother. 1993, 37, 1127-1131.
418. Young, S. D.; Britcher, S. F; Tran, L. O.; Payne, L. S.; Lumma, W C.; Lyle, T. A.; Huff, J. R.; Anderson, P. S.; Olsen, D. B.; Carroll, S. S. Antimicrob. Agents Chemother. 1995, 39, 2602-2605.
419. Hargrave, K. D.; Proudfoot, J. R.; Grozinger, K. G.; Cullen, E.; Kapadia, S. R.; Patel, U. R.; Fuchs, V. U.; Mauldin, S. C.; Vitous, J.; Behnke, M. L. et al. J. Med. Chem. 1991, 34, 2231-2241.
420. Romero, D. L.; Morge, R. A.; Genin, M. J.; Biles, C.; Busso, M.; Resnick, L.; Althaus, I. W; Reusser, F; Thomas, R. C.; Tarpley, W G. J. Med. Chem. 1993, 36, 1505-1508.
421. Tucker, T J.; Lyle, T A.; Wiscount, C. M.; Britcher, S. F; Young, S. D.; Sanders, W M.; Lumma, W C.; Goldman, M. E.; O'Brien, J. A.; Ball, R. G. et al. J. Med. Chem. 1994, 37, 2437-2444.
422. Oprea, T I.; Davis, A. M.; Teague, S. J.; Leeson, P. D. J. Chem. Inf. Comput Sei. 2001, 41, 1308-1315.
423. Wu, J. C.; Warren, T. C.; Adams, J.; Proudfoot, J.; Skiles, J.; Raghavan, P; Perry, C.; Potocki, I.; Farina, P. R.; Grob, P. M. Biochemistry 1991, 30, 2022-2026.
424. Cohen, K. A.; Hopkins, J.; Ingraham, R. H.; Pargellis, C.; Wu, J. C.; Palladino, D. E.; Kinkade, P.; Warren, T. C.; Rogers, S.; Adams, J. et al. J. Biol. Chem. 1991, 266, 14670-14674.
425. Kohlstaedt, L. A.; Wang, J.; Friedman, J. M.; Rice, P. A.; Steitz, T A. Science 1992, 256, 1783-1790.
426. Ren, J.; Esnouf, R.; Garman, E.; Somers, D.; Ross, C.; Kirby, I.; Keeling, J.; Darby, G.; Jones, Y; Stuart, D. et al. Nat. Struct. Biol. 1995, 2, 293-302.
427. Sarafianos, S. G.; Das, K.; Hughes, S. H.; Arnold, E. Curr. Opin. Struct. Biol. 2004, 14, 716-730.
428. Shih, C.-K.; Rose, J. M.; Hansen, G. L.; Wu, J. C.; Bacolla, A.; Griffin, J. A. Proc. Natl. Acad. Sei. USA 1991, 88, 9878-9882.
429. Richman, D.; Shih, C.-K.; Lowy, I.; Rose, J.; Prodanovich, P.; Goff, S.; Griffin, J. Proc. Natl. Acad. Sei. USA 1991, 88, 11241-11245;
430. Richman, D. D.; Havlir, D.; Corbeil, J.; Looney, D.; Ignacio, C.; Spector, S. A.; Sullivan, J.; Cheeseman, S.; Barringer, K.; Pauletti, D. J. Virol. 1994, 68, 1660-1666.
431. Montaner, J. S. G.; Reiss, P.; Cooper, D.; Vella, S.; Harris, M.; Conway, B.; Wainberg, M. A.; Smith, D.; Robinson, P.; Hall, D. et al. JAMA 1998, 279, 930-937.
432. Albrecht, M. A.; Bosch, R. J.; Hammer, S. M.; Liou, S. H.; Kessler, H.; Para, M. F; Eron, J.; Valdez, H.; Dehlinger, M.; Katzenstein, D. A. N. Engl. J. Med. 2001, 345, 398-407.
433. Harris, M. J. HIVTher. 1999, 4, 37-40.
434. Kashman, Y; Gustafson, K. R.; Fuller, R.; Cardellina, H.; McMahon, J. B.; Currens, M. J.; Buckheit, R. W, Jr.; Hughes, S. H.; Cragg, G. M.; Boyd, M. R. J. Med. Chem. 1992, 35, 2735-2743.
435. Currens, M. J.; Gulakowski, R. J.; Mariner, J. M.; Moran, R. A.; Buckheit, R. W, Jr.; Gustafson, K. R.; McMahon, J. B.; Boyd, M. R. J. Pharmacol. Exp. Ther. 1996, 279, 645-651.
436. Baba, M.; Tanaka, H.; De Clercq, E.; Pauwels, R.; Balzarini, J.; Schols, D.; Nakashima, H.; Perno, C. F; Walker, R. T; Miyasaka, T Biochem. Biophys. Res. Commun. 1989, 165, 1375-1381.
437. Quan, Y; Motakis, D.; Buckheit, R., Jr.; Xu, Z. Q.; Flavin, M. T; Parniak, M. A.; Wainberg, M. A. Antivir. Ther. 1999, 4, 203-209.
438. Wlodawer, A.; Miller, M.; Jaskolski, M.; Sathyanarayana, B. K.; Baldwin, E.; Weber, I. T; Selk, L. M.; Clawson, L.; Schneider, J.; Kent, S. B. H. Science 1989,245, 616;
439. Navia, M. A.; Fitzgerald, P. M. D.; McKeever, B. M.; Leu, C.-T; Heimbach, WC.; Herber, W K.; Sigal, I. S.; Darke, P. L.; Springer, J. P. Nature 1989, 337, 615-620.
440. Roberts, N. A.; Martin, J. A.; Kinchington, D.; Broadhurst, A. V; Craig, J. C.; Duncan, I. B.; Galpin, S. A.; Handa, B. K.; Kay, J.; Krohn, A. et al. Science 1990, 248, 358-361.
441. Kaldor, S. W; Kalish, V J.; Davies, J. F; Shetty, B. V; Fritz, J. E.; Appelt, K.; Burgess, J. A.; Campanale, K. M.; Chirgadze, N. Y; Clawson, D. K. et al. J. Med. Chem 1997, 40, 3979-3985.
442. Kim, E. E.; Baker, C. T; Dwyer, M. D.; Murcko, M. A.; Rao, B. G.; Tung, R. D.; Navia, M. A. J. Am. Chem. Soc. 1995, 117, 1181-1182.
443. Colonno, R. J.; Thiry, A.; Limoli, K.; Parkin, N. Antimicrob. Agents Chemother. 2003, 47, 1324-1333.
444. Surleraux, D. L. N. G.; Tahri, A.; Verschueren, W G.; Pille, G. M. E.; de Kock, H. A.; Jonckers, T H. M.; Peeters, A.; De Meyer, S.; Azijn, H.; Pauwels, R. et al. J. Med. Chem. 2005, 48, 1813-1822.
445. Erickson, J.; Neidhart, D. J.; VanDrie, J.; Kempf, D. J.; Wang, X. C.; Norbeck, D. W; Plattner, J. J.; Rittenhouse, J. W; Turon, M.; Wideburg, N. et al. Science 1990, 249, 527-533.
446. Kempf, D. J.; Norbeck, D. W; Codacovi, L.; Wang, X. C.; Kohlbrenner, W. E.; Wideburg, N. E.; Paul, D. A.; Knigge, M. F; Vasavanonda, S.; Craig-Kennard, A. et al. J. Med. Chem. 1990, 33, 2687-2689.
447. Clavel, F; Hance, A. J. N. Engl. J. Med. 2004, 350, 1023-1035.
448. Sham, H. L.; Kempf, D. J.; Molla, A.; Marsh, K. C.; Kumar, G. N.; Chen, C.-M.; Kati, W; Stewart, K.; Lal, R.; Hsu, A. et al. Antimicrob. Agents Chemother. 1998, 42, 3218-3224.
449. Vacca, J. P.; Guare, J. P.; deSolms, S. J.; Sanders, W. M.; Giuliani, E. A.; Young, S. D.; Darke, P. L.; Zugay, J.; Sigal, I. S.; Schleif, W. A. J. Med. Chem. 1991, 34, 1225-1228.
450. Dorsey, B. D.; Levin, R. B.; McDaniel, S. L.; Vacca, J. P.; Guare, J. P; Darke, P. L.; Zugay, J. A.; Emini, E. A.; Schleif, W A.; Quintero, J. C. et al. J. Med. Chem 1994, 37, 3443-3451.
451. Thaisrivongs, S.; Tomich, P. K.; Watenpaugh, K. D.; Chong, K.-T.; Howe, W J.; Yang, C.-P; Strohbach, J. W.; Turner, S. R.; McGrath, J. P; Bohanon, M. J. et al. J. Med. Chem. 1994, 37, 3200-3204.
452. Hazuda, D. J.; Felock, P; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J. A.; Espeseth, A.; Gabryelski, L.; Schleif, W; Blau, C. et al. Science 2000, 6, 646-650.
453. Zhuang, L.; Wai, J. S.; Embrey, M. W; Fisher, T E.; Egbertson, M. S.; Payne, L. S.; Guare, J. P.; Vacca, J. P; Hazuda, D. J.; Felock, J. et al. J. Med. Chem. 2003, 46, 453-456.
454. Billich, A. Curr. Opin. Investig. Drugs 2003, 4, 206-209.
455. Goldgur, Y; Craigie, R.; Cohen, G. H.; Fujiwara, T; Yoshinaga, T; Fujishita, T; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. R. Proc. Natl. Aead. Sei. USA 1999, 96, 13040-13043.
456. Fikkert, V; Hombrouck, A.; van Remoortel, B.; de Maeyer, M.; Pannecouque, C.; de Clercq, E.; Debyser, Z.; Witvrouw, M. AIDS 2004, 18, 2019-2028.
457. Bray, B. L. Nat. Rev. Drug Disc. 2003, 2, 587-593.
458. Tagat, J. R.; McCombie, S. W; Nazareno, D.; Labroli, M. A.; Xiao, Y; Steensma, R. W; Strizki, J. M.; Baroudy, B. M.; Cox, K.; Lachowicz, J. et al. J. Med. Chem. 2004, 47, 2405-2408.
459. Roden, D. M. N. Engl. J. Med. 2004, 350, 1013-1022.
460. Mullin, R. Chem. Eng. News 2005, Feb 28, 29-39.
461. Ganellin, C. R. Chem. Int. (IUPAC News Magazine) 2001, 23, 43-45.
462. Brent, J. University of Minnesota CLA Today (1998-99 Annual Report) 1999,, 10-13.
463. For example, respectively: the long-http://www.depts.drew.edu/resmed, accessed Aug 2006); Drug Metabolism for Medicinal Chemists short course that P. Erhardt offers on-site; and, a long-distance Continuing Learning Program in Medicinal Chemistry offered by the University of Nottingham, UK. (http://www.nottingham.ac.uk/, accessed Aug 2006).
464. Wright, E. G. Modern Drug Disc. 2000, Oct, 69-70.
465. Ledbetter, E. Modern Drug Disc. 2000, Apr/May, 25-28 and 81-84.
466. Jacobs, M. Chem. Eng. News 2000, Apr 10, 39-44.
467. Jacobs, M. Chem. Eng. News 2001, Jan 15, 33.
468. US National Academies' National Research Council (NRC) report entitled A Patent System for the 21st Century, 2004 available at http://books.nap.edu/catalog/10976.html (accessed Aug 2006).
469. Hanson, D. J. Chem. Eng. News 2000, Sept 11, 19-20.
470. Kaminski, M. D. Modern Drug Disc. 2001, Jan, 36-37.
471. Erhardt, P. W Chem. Int (IUPAC Newsletter) 2002, 24, 16.
472. Elliston, K. O. (as quoted in) Chem. Eng. News 2005, Feb 14, 54-55.